24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
Inflammatory Bowel Disease, Celiac Are Linked: ReviewCOVID-19 Rates May Be Lower Than Thought for Pregnant WomenAs Postponed Surgeries Resume, Can U.S. Hospitals Handle the Strain?Most Americans Still More Worried About COVID-19 Spread Than the EconomyWhat to Know If You're Headed to College With Asthma or AllergiesCoronavirus Was Already Spreading in U.S. in January: StudyAHA News: Inherited High Cholesterol May Be Common in People With Heart DiseaseDVT Clots Strike Many Critically Ill COVID-19 Patients: StudyYour Eyewear and COVID-19 SafetyPandemic Having More Impact on U.S. Hospitals Than Thought: StudyBig Need for Blood Donations as Postponed Surgeries ResumeAs Hard-Hit Areas of America Show Slowing in Coronavirus Cases, Other Regions See SpikesHydroxychloroquine May Worsen Odds for Cancer Patients With COVID-191 in 10 Hospitalized COVID-19 Patients With Diabetes Dies: StudyAHA News: How Bacteria in Your Gut Interact With the Mind and BodyMusic Might Help Soothe Ailing HeartsCould an Injected Electrode Control Your Pain Without Drugs?100,000 Dead, 40 Million Unemployed: America Hits Grim Pandemic MilestonesFDA Approves IV Artesunate for Severe Malaria'Silent' COVID-19 More Widespread Than ThoughtDrug Combos May Be Advance Against Heart FailurePollen Fragments Linger After Rains, Leaving Allergy Sufferers MiserableA New Hip or Knee Can Do a Marriage Good, Study FindsOnly Half of Americans Say They'd Get a Coronavirus Vaccine: SurveyAlzheimer's Gene Linked to Severe COVID-19 RiskCoronavirus Cases Ticking Upwards in Nearly a Dozen U.S. StatesLockdown Got You Down? Experts Offer Tips to De-StressCould a Hormone Help Spur High Blood Pressure?Nursing Homes Are Ground Zero for COVID-19Getting Back to Work Safely After LockdownRemdesivir Will Not Be Enough to Curb COVID-19, Study FindsOutdoor Swimming Pools Not a COVID-19 Risk: ExpertStrokes Are Deadlier When They Hit COVID-19 PatientsAHA News: How to Accurately Measure Blood Pressure at HomeU.S. Earmarks $1.2 Billion for New Vaccine Deal as Coronavirus Deaths Near 95,000During the Pandemic, How Safe Is the Great American Summer Vacation?COVID-19 Damages Lungs Differently From the Flu: StudyMore Evidence Hydroxychloroquine Won't Help, May Harm COVID-19 PatientsYour Sleep Habits May Worsen Your AsthmaExtra Pounds Could Bring More Painful JointsCOVID Can Complicate Pregnancy, Especially If Mom Is ObeseWHO Predicts COVID-19 Will Take Heavy Toll in AfricaCombining Remdesivir With Other Meds Could Boost COVID-Fighting PowerMultiple Sclerosis Ups Odds for Heart Trouble, StrokeAHA News: Not Wanting to Burden Busy Hospitals, She Disregarded Heart Attack SignsExperimental Vaccines Shield Monkeys From CoronavirusHeart Attack Cases at ERs Fall by Half – Are COVID Fears to Blame?Asthma Ups Ventilator Needs of Younger Adults With COVID-19: Study1 in 5 Hospitalized NYC COVID-19 Patients Needed ICU CareObesity Ups Odds for Dangerous Lung Clots in COVID-19 Patients
Questions and AnswersLinks
Related Topics

Diabetes

Vitamin D Supplements Don't Prevent Type 2 Diabetes: Study

HealthDay News
by -- Steven Reinberg
Updated: Jun 10th 2019

new article illustration

MONDAY, June 10, 2019 (HealthDay News) -- Vitamin supplements don't appear to prevent type 2 diabetes in those at highest risk for the disease, a new study finds.

Some studies have suggested that low vitamin D levels might increase the odds of developing diabetes and that boosting levels could prevent it, but these findings throw cold water on these assumptions.

In this study funded by the U.S. National Institutes of Health (NIH), more than 2,400 people aged 30 and older across the United States were involved. Researchers randomly assigned half of them to take 4,000 units a day of vitamin D and the other half to take a placebo.

After nearly three years, 24.2% of those taking vitamin D developed diabetes, as did 26.7% of those taking the placebo. This difference isn't statistically significant, researchers said.

"In addition to the study's size, one of its major strengths is the diversity of its participants, which enabled us to examine the effect of vitamin D across a large variety of people," lead author Dr. Anastassios Pittas said in an NIH news release. "When the study ended, we found no meaningful difference between the two groups regardless of age, sex, race or ethnicity."

Pittas is a professor and co-director of the Diabetes and Lipid Center at Tufts University Medical Center in Boston.

The report was published June 7 in the New England Journal of Medicine to coincide with its presentation at a meeting of the American Diabetes Association, in San Francisco.

More information

The American Diabetes Association offers more details about type 2 diabetes.